TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Double-masked, Multicenter, Randomized, Sham Injection-controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus
Brief Summary: This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study of the efficacy and safety of ranibizumab injection in patients with clinically significant macular edema with center involvement (CSME-CI) secondary to diabetes mellitus (Type 1 or 2). This study is identical in design to study NCT00473330 (Protocol ID FVF4170g).

The open-label extension phase of the study was stopped after receiving FDA approval of the study drug (ranibizumab) for diabetic macular edema.


Options:
A: Arm Label: Avastin Injection Group (AIG); Type: EXPERIMENTAL; Interventions: Drug: Avastin (bevacizumab) | Arm Label: Sham Injection Group (SIG); Type: SHAM_COMPARATOR; Interventions: Other: Sham injection | Intervention Type: DRUG; Name: Avastin (bevacizumab); Assigned to Arm(s): Avastin Injection Group (AIG) | Intervention Type: OTHER; Name: Sham injection; Assigned to Arm(s): Sham Injection Group (SIG)
B: Arm Label: Ranibizumab 0.3 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Arm Label: Ranibizumab 0.5 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Arm Label: Sham injection/ranibizumab 0.5 mg; Type: SHAM_COMPARATOR; Interventions: Drug: Sham injection | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab 0.3 mg, Ranibizumab 0.5 mg | Intervention Type: DRUG; Name: Sham injection; Assigned to Arm(s): Sham injection/ranibizumab 0.5 mg
C: Arm Label: Saline Injection; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Arm Label: Ranibizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ranibizumab | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Saline Injection
D: Arm Label: 7 days; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bevacizumab | Arm Label: 20 days; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bevacizumab | Arm Label: sham; Type: SHAM_COMPARATOR; Interventions: Other: sham | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): 20 days, 7 days | Intervention Type: OTHER; Name: sham; Assigned to Arm(s): sham

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase1 Effectiveness of a Modified Constraint-Induced Movement Therapy Program in Rehabilitation of Arm Paresis in Children With Cerebral Palsy: a Cross-Over Study
Brief Summary: The purpose of this study is to determine if a modified protocol of constraint-induced movement therapy (CIT) is effective in rehabilitation treatment of arm paresis in children with cerebral palsy. In these children one main problem the non-use of the affected arm. Many studies showed that the non-use phenomenon can by reversed by the CIT, a rehabilitation program consisting of 15 days of restraining the unaffected arm plus a daily intensive (6 hours/day) physiotherapy training of the paretic arm. The present study aims at evaluating if a shortened CIT protocol (restraining device plus only 2 weekly hours of physiotherapy) is effective in improving use and function of children paretic arm


Options:
A: Arm Label: Real rTMS combined with CIT; Type: EXPERIMENTAL; Interventions: Device: real rTMS combined with constraint induced therapy | Arm Label: Sham rTMS combined with CIT; Type: SHAM_COMPARATOR; Interventions: Device: sham rTMS combined with constraint induced therapy | Intervention Type: DEVICE; Name: real rTMS combined with constraint induced therapy; Assigned to Arm(s): Real rTMS combined with CIT | Intervention Type: DEVICE; Name: sham rTMS combined with constraint induced therapy; Assigned to Arm(s): Sham rTMS combined with CIT
B: Intervention Type: BEHAVIORAL; Name: Pediatric Constraint-Induced Movement therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Conventional pediatric motor rehabilitation therapy; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Modified Constraint-induced movement therapy; Assigned to Arm(s): N/A
D: Arm Label: rTMS and CIMT; Type: EXPERIMENTAL; Interventions: Procedure: Repetitive Transcranial Magnetic Stimulation (rTMS), Procedure: Constraint-induced movement therapy (CIMT) | Arm Label: rTMS and no CIMT; Type: EXPERIMENTAL; Interventions: Procedure: Repetitive Transcranial Magnetic Stimulation (rTMS) | Arm Label: Sham and CIMT; Type: EXPERIMENTAL; Interventions: Procedure: Constraint-induced movement therapy (CIMT) | Arm Label: Sham and no CIMT; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Repetitive Transcranial Magnetic Stimulation (rTMS); Assigned to Arm(s): rTMS and CIMT, rTMS and no CIMT | Intervention Type: PROCEDURE; Name: Constraint-induced movement therapy (CIMT); Assigned to Arm(s): Sham and CIMT, rTMS and CIMT

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Structured Exercise Program Versus Hypocaloric Hyperproteic Diet on the Reproductive Function in Obese Anovulatory Infertile Patients With Polycystic Ovary Syndrome: a 24-Week Prospective Study.
Brief Summary: Lifestyle modifications are successfully employed in polycystic ovarian syndrome (PCOS) improving menstrual cycles and fertility. Unfortunately, the compliance over the time is very low. Recently, we have showed a high adherence to structured exercise training (SET) program in women with PCOS. The current study will be aimed to compare the efficacy of the SET program with a diet program on the reproductive function in obese anovulatory infertile PCOS patients.


Options:
A: Intervention Type: BEHAVIORAL; Name: Structured exercise training; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Hypocaloric hyperproteic diet; Assigned to Arm(s): N/A
B: Arm Label: strength training; Type: EXPERIMENTAL; Interventions: Behavioral: strength training | Arm Label: interval training; Type: EXPERIMENTAL; Interventions: Behavioral: interval training | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: strength training; Assigned to Arm(s): strength training | Intervention Type: BEHAVIORAL; Name: interval training; Assigned to Arm(s): interval training
C: Arm Label: Low-frequency electro-acupuncture; Type: EXPERIMENTAL; Interventions: Procedure: Electroacupuncture | Arm Label: Physical exercise; Type: EXPERIMENTAL; Interventions: Procedure: Physical exercise | Arm Label: Untreated control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Untreated control | Intervention Type: PROCEDURE; Name: Electroacupuncture; Assigned to Arm(s): Low-frequency electro-acupuncture | Intervention Type: PROCEDURE; Name: Physical exercise; Assigned to Arm(s): Physical exercise | Intervention Type: PROCEDURE; Name: Untreated control; Assigned to Arm(s): Untreated control
D: Intervention Type: DIETARY_SUPPLEMENT; Name: Low carbohydrate; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients
Brief Summary: The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and 20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride levels.


Options:
A: Intervention Type: DRUG; Name: rosuvastatin; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Rosuvastatin (Crestor); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Ezetimibe; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: rosuvastatin calcium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atorvastatin; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Blood Pressure Care for Korean Americans
Brief Summary: The primary objective of the proposed clinical trials is to compare the differential reduction in blood pressure in underserved hypertensive adult Korean American. The study is designed to test the effectiveness of a comprehensive self-help intervention program.


Options:
A: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: Telemedicine intervention | Intervention Type: BEHAVIORAL; Name: Telemedicine intervention; Assigned to Arm(s): Arm 1
B: Intervention Type: BEHAVIORAL; Name: Self-Help Intervention Program-High Blood Pressure; Assigned to Arm(s): N/A
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminders of medicines intake | Intervention Type: BEHAVIORAL; Name: SMS reminders of medicines intake; Assigned to Arm(s): Intervention
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: MedSentry System; Type: EXPERIMENTAL; Interventions: Device: MedSentry System | Intervention Type: DEVICE; Name: MedSentry System; Assigned to Arm(s): MedSentry System

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Blood Pressure Care for Korean Americans
Brief Summary: The primary objective of the proposed clinical trials is to compare the differential reduction in blood pressure in underserved hypertensive adult Korean American. The study is designed to test the effectiveness of a comprehensive self-help intervention program.


Options:
A: Arm Label: Exercise Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Intervention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Wellness control | Intervention Type: BEHAVIORAL; Name: Wellness control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Physical Activity Intervention; Assigned to Arm(s): Exercise Intervention
B: Intervention Type: BEHAVIORAL; Name: Self-Help Intervention Program-High Blood Pressure; Assigned to Arm(s): N/A
C: Arm Label: Health Literacy; Type: EXPERIMENTAL; Interventions: Behavioral: Health literacy, health message | Intervention Type: BEHAVIORAL; Name: Health literacy, health message; Assigned to Arm(s): Health Literacy
D: Arm Label: Group 2: community video group; Type: EXPERIMENTAL; Interventions: Behavioral: patient role played community video, Behavioral: Community video group | Arm Label: Group three: both videos group; Type: EXPERIMENTAL; Interventions: Behavioral: both videos group | Arm Label: Group four: pamphlet group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Pamphlet group | Arm Label: Group one: knowledge video group; Type: EXPERIMENTAL; Interventions: Behavioral: physician-led knowledge video, Behavioral: knowledge video | Intervention Type: BEHAVIORAL; Name: patient role played community video; Assigned to Arm(s): Group 2: community video group | Intervention Type: BEHAVIORAL; Name: both videos group; Assigned to Arm(s): Group three: both videos group | Intervention Type: BEHAVIORAL; Name: Pamphlet group; Assigned to Arm(s): Group four: pamphlet group | Intervention Type: BEHAVIORAL; Name: physician-led knowledge video; Assigned to Arm(s): Group one: knowledge video group | Intervention Type: BEHAVIORAL; Name: Community video group; Assigned to Arm(s): Group 2: community video group | Intervention Type: BEHAVIORAL; Name: knowledge video; Assigned to Arm(s): Group one: knowledge video group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Blood Pressure Care for Korean Americans
Brief Summary: The primary objective of the proposed clinical trials is to compare the differential reduction in blood pressure in underserved hypertensive adult Korean American. The study is designed to test the effectiveness of a comprehensive self-help intervention program.


Options:
A: Arm Label: Standard Care; Type: OTHER; Interventions: Other: Standard Care | Arm Label: Extended Care Management; Type: EXPERIMENTAL; Interventions: Other: Extended Care Management | Intervention Type: OTHER; Name: Extended Care Management; Assigned to Arm(s): Extended Care Management | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
B: Arm Label: Group A; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Behavioral: Quitline Service + 10 automated monitoring calls | Arm Label: Group C; Type: EXPERIMENTAL; Interventions: Behavioral: Quitline service + 20 automated monitoring calls | Intervention Type: BEHAVIORAL; Name: Quitline Service + 10 automated monitoring calls; Assigned to Arm(s): Group B | Intervention Type: BEHAVIORAL; Name: Quitline service + 20 automated monitoring calls; Assigned to Arm(s): Group C
C: Arm Label: Telephone counselling; Type: EXPERIMENTAL; Interventions: Device: Standard 15-minute telephone counselling, Device: Proactive telephone counselling | Arm Label: Proactive telephone counselling; Type: EXPERIMENTAL; Interventions: Device: Proactive telephone counselling | Arm Label: web-based smoking cessation programme; Type: EXPERIMENTAL; Interventions: Device: Interactive web-based smoking cessation programme | Arm Label: Self-help material; Type: ACTIVE_COMPARATOR; Interventions: Device: Self-help material | Intervention Type: DEVICE; Name: Standard 15-minute telephone counselling; Assigned to Arm(s): Telephone counselling | Intervention Type: DEVICE; Name: Proactive telephone counselling; Assigned to Arm(s): Proactive telephone counselling, Telephone counselling | Intervention Type: DEVICE; Name: Interactive web-based smoking cessation programme; Assigned to Arm(s): web-based smoking cessation programme | Intervention Type: DEVICE; Name: Self-help material; Assigned to Arm(s): Self-help material
D: Intervention Type: BEHAVIORAL; Name: Self-Help Intervention Program-High Blood Pressure; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Chloroquine as a Therapeutic Option for Mild Post Malaria Anaemia
Brief Summary: The pathogenesis of post-malaria anaemia is multifactorial. Iron supplementation remains the mainstay of management of moderate and severe anaemia; however the management of mild anaemia (Hb 80-110g/l) is problematic as population supplementation studies of children in malaria endemic areas demonstrate adverse effects in children with mild anaemia. We hypothesize that the anti-inflammatory, anti-malarial and anti-macrophageal iron loading effects of chloroquine could make it a useful drug in the management of mild post malaria anaemia. To test this hypothesis, we plan to randomize children (aged 12 months to 6 years) with post malaria anaemia (Hb 70-110g/l) to receive a standard anti-malarial treatment, co-artemether . All children with parasitologic cure after three days on treatment will be randomised to receive either weekly chloroquine or weekly placebo starting from day 10 till day 90. By comparing the curve of haemoglobin change between day 3 and day 30 in the placebo arms of the two groups, we will test the effect of chloroquine vs. ACT treatment on macrophageal iron loading and release in acute clinical malaria. By comparing the haemoglobin change between day 3 and day 90 between the weekly chloroquine arms and the weekly placebo arms we will test the longer-term anti-inflammatory and anti- malarial effects of weekly chloroquine prophylaxis. In addition to the primary endpoint, we plan to assess potential mechanisms of action by determining parasite clearance, peripheral cytokine production and iron flux


Options:
A: Intervention Type: DRUG; Name: sulfadoxine-pyrimethamine; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: artesunate-amodiaquine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: sulphadoxine-pyrimethamine; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Intrarectal quinine; Assigned to Arm(s): N/A
D: Arm Label: Treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chloroquine | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Chloroquine; Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Parallel-group, Open-labelled, Multinational Trial Comparing the Efficacy and Safety of Insulin Detemir (Levemir®) Versus Human Insulin (NPH Insulin), Used in Combination With Insulin Aspart as Bolus Insulin, in the Treatment of Pregnant Women With Type 1 Diabetes
Brief Summary: This trial is conducted in Africa, Europe, North and South America and Oceania. The aim of this trial is to compare the effect and safety on blood glucose control in pregnant women with type 1 diabetes of a modern insulin analogue (insulin detemir) and human insulin (NPH insulin) given as long-acting insulin in combination with a short-acting insulin (insulin aspart).


Options:
A: Arm Label: Insulin detemir; Type: EXPERIMENTAL; Interventions: Drug: insulin detemir, Drug: insulin aspart | Arm Label: Neutral Protamine Hagedorn (NPH) insulin; Type: ACTIVE_COMPARATOR; Interventions: Drug: NPH insulin, Drug: insulin aspart | Intervention Type: DRUG; Name: insulin detemir; Assigned to Arm(s): Insulin detemir | Intervention Type: DRUG; Name: NPH insulin; Assigned to Arm(s): Neutral Protamine Hagedorn (NPH) insulin | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): Insulin detemir, Neutral Protamine Hagedorn (NPH) insulin
B: Arm Label: candesartan; Type: EXPERIMENTAL; Interventions: Drug: candesartan | Arm Label: placebo; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: candesartan; Assigned to Arm(s): candesartan
C: Intervention Type: DRUG; Name: human insulin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): N/A
D: Arm Label: Levemir; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin | Arm Label: NPH; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin | Intervention Type: DRUG; Name: Insulin; Assigned to Arm(s): Levemir, NPH

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary PCI Patients (The SAFE-DEPART Trial)
Brief Summary: The purpose of this study is to determine if early hospital discharge (at 48-72 hours), is feasible, safe, cost-effective, and/or improves compliance with medications, positive lifestyle changes and quality-of-life, in low-risk patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (primary PCI).


Options:
A: Arm Label: Diabetes Medication Choice decision aid; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Medication Choice decision aid | Arm Label: Usual Care; Type: OTHER; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Diabetes Medication Choice decision aid; Assigned to Arm(s): Diabetes Medication Choice decision aid | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: SHHE Peridischarge intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SHHE Peridischarge Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SHHE Peridischarge Intervention; Assigned to Arm(s): SHHE Peridischarge intervention
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminders of medicines intake | Intervention Type: BEHAVIORAL; Name: SMS reminders of medicines intake; Assigned to Arm(s): Intervention
D: Intervention Type: BEHAVIORAL; Name: Early hospital discharge facilitated by close nurse practitioner follow-up; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary PCI Patients (The SAFE-DEPART Trial)
Brief Summary: The purpose of this study is to determine if early hospital discharge (at 48-72 hours), is feasible, safe, cost-effective, and/or improves compliance with medications, positive lifestyle changes and quality-of-life, in low-risk patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (primary PCI).


Options:
A: Intervention Type: BEHAVIORAL; Name: Early hospital discharge facilitated by close nurse practitioner follow-up; Assigned to Arm(s): N/A
B: Intervention Type: PROCEDURE; Name: Percutaneous coronary angioplasty/intervention (PCI); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Anti-ischemic drug therapy; Assigned to Arm(s): N/A
C: Arm Label: Personalized Risk Information; Type: ACTIVE_COMPARATOR; Interventions: Other: Personalized Heart Attack and Stroke Risk | Arm Label: Standard Education; Type: OTHER; Interventions: Other: Standard Education | Intervention Type: OTHER; Name: Personalized Heart Attack and Stroke Risk; Assigned to Arm(s): Personalized Risk Information | Intervention Type: OTHER; Name: Standard Education; Assigned to Arm(s): Standard Education
D: Intervention Type: BEHAVIORAL; Name: Pharmacist intervention; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Research Project
Brief Summary: The five Teen-LABS clinical centers use standardized techniques to assess the short and longer-term safety and efficacy of bariatric surgery in adolescents compared to adults.


Options:
A: Arm Label: Stapleless one anastomosis gastric bypass; Type: EXPERIMENTAL; Interventions: Procedure: Laparoscopic one anastomosis gastric bypass | Arm Label: Staple use mini-gastric bypass; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic one anastomosis gastric bypass | Arm Label: Hypocaloric diet therapy; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Hypocaloric diet therapy | Intervention Type: PROCEDURE; Name: Laparoscopic one anastomosis gastric bypass; Assigned to Arm(s): Staple use mini-gastric bypass, Stapleless one anastomosis gastric bypass | Intervention Type: DIETARY_SUPPLEMENT; Name: Hypocaloric diet therapy; Assigned to Arm(s): Hypocaloric diet therapy
B: N/A
C: Arm Label: Treatment group; Type: ACTIVE_COMPARATOR; Interventions: Device: placement of g-Cath EZ suture anchors, Behavioral: Diet and Exercise | Arm Label: Sham Group; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham procedure, Behavioral: Diet and Exercise | Intervention Type: DEVICE; Name: placement of g-Cath EZ suture anchors; Assigned to Arm(s): Treatment group | Intervention Type: PROCEDURE; Name: Sham procedure; Assigned to Arm(s): Sham Group | Intervention Type: BEHAVIORAL; Name: Diet and Exercise; Assigned to Arm(s): Sham Group, Treatment group
D: Arm Label: Adolescents with severe obesity; Type: N/A; Interventions: N/A

Answer: D